Accuracy of diabetic retinopathy screening not affected by mydriasis

Article

An investigation published in the Archives of Ophthalmology has indicated that the accuracy of screening for diabetic retinopathy (DR) is affected by the qualifications of retinal photographers but not by mydriasis.

An investigation published in the Archives of Ophthalmology has indicated that the accuracy of screening for diabetic retinopathy (DR) is affected by the qualifications of retinal photographers but not by mydriasis.

The team, led by Dr Peter Bragge of the National Trauma Research Institute, Melbourne, Australia, researched how mydriasis and the medical qualifications of photographers who take retinal photographs influence the screening accuracy for DR.

The researchers analysed studies that measured the sensitivity and specificity of tests designed to detect any DR, sight-threatening DR or macular oedema. The effects of variations in mydriatic status and in the medical qualifications of photographers on sensitivity and specificity were looked at through random-effects logistic regression.

It was found that the only group of tests that were consistent enough for meta analysis was the "any DR" category. In these studies no significant influence to sensitivity or specificity was found when the mydriatic status varied. This was also true for variations in medical qualifications of photographers. However, the specificity of detection of any DR was higher in screening methods using a photographer with specialist medical or eye qualifications.

It was concluded that outreach screening is a successful alternative to on-site specialist examination. The procedure is ideal for screening high-risk diabetic retinopathy patients in rural areas or areas with limited screening facilities. However, the study was confined to the presence or absence of DR and future work should use consistent DR classification schemes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.